HCD8MAG15K17PMX Display Image

Human CD8+ T Cell MAG Premixed 17plx Kit

Code: HCD8MAG15K17PMX D2-231

Application

Analytes: GM-CSF, sCD137, IFNγ, sFas, sFasL, Granzyme A, Granzyme B, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, MIP-1α, MIP-1β, TNF-α, Perforin Rec...


read more

Your Price
£4,457.41 EACH
£5,348.89 inc. VAT

Application

Analytes: GM-CSF, sCD137, IFNγ, sFas, sFasL, Granzyme A, Granzyme B, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, MIP-1α, MIP-1β, TNF-α, Perforin Recommended Sample type: serum, plasma or tissue/cell lysate and culture supernatant Recommended Sample dilution: Neat Assay Run Time: Overnight Research Category: Inflammation & Immunology

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

CD8+ T cells (also known as cytotoxic T cells, cytolytic T cells and killer T cells) belong to a sub-group of T cells capable of inducing the death of infected somatic or tumor cells. T cells that bind weakly to Major Histocompatibility Complex (MHC) self-antigens are positively selected into single-positive CD4+ or CD8+ T cells in the thymus. Those CD8+ T cells that survive and mature after activation become cytotoxic cells, expressing T-cell receptors (TCRs) capable of recognizing specific antigenic peptides bound to Class I MHC molecules and the glycoprotein CD8. Affinity between the CD8 protein and the MHC molecule helps to keep the cytotoxic T cell and target closely bound during antigen specific activation. Once activated, CD8+ T cells are generally classified as having a predefined cytotoxic role within the immune system and undergo IL-2 induced clonal expansion, which increases the number of cells specific for the target antigen. The CD8+ T cells then travel throughout the body in search of antigen-positive somatic/tumor cells. The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume. Panel Type: Cytokines/Chemokines

Legal Information

xMAP is a registered trademark of Luminex Corp

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Sensitivity: Refer to kit protocol for sensitivities of individual biomarkers.

Specificity

Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Storage and Stability

Recommended storage for kit components is 2 - 8°C.

assay rangestandard curve range: 1-5,000 pg/mL(IFNγ), standard curve range: 1-3,500 pg/mL(MIP-1α), standard curve range: 10-50,000 pg/mL(sFasL), standard curve range: 2-7,500 pg/mL(IL-2), standard curve range: 20-100,000 pg/mL(Granzyme A), standard curve range: 2-10,000 pg/mL(IL-4), standard curve range: 1-5,000 pg/mL(Granzyme B), standard curve range: 4-15,000 pg/mL(GM-CSF), standard curve range: 1-5,000 pg/mL(IL-5), standard curve range: 400-1,650,000 pg/mL(sFas), standard curve range: 0.5-2,000 pg/mL(TNFα), standard curve range: 2-10,000 pg/mL(sCD137), standard curve range: 7-30,000 pg/mL(MIP-1β), standard curve range: 0.4-1,500 pg/mL(IL-6), standard curve range: 10-50,000 pg/mL(Perforin), standard curve range: 2-7,500 pg/mL(IL-13), standard curve range: 5-20,000 pg/mL(IL-10)
compatibilityconfigured for Premixed
detection methodfluorometric (Luminex xMAP)
manufacturer/tradenameMilliplex®
Quality Level200
shipped inwet ice
species reactivityhuman
technique(s)multiplexing: suitable
This product has met the following criteria: